Alliance Pharma PLC APH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 43.50
- Day Range
- GBX 42.37–43.95
- 52-Week Range
- GBX 24.55–46.00
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 23.00 Bil
- Volume/Avg
- 1.6 Mil / 1.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 8.89
- Price/Sales
- 1.29
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. The company generates the majority of its revenue from the Consumer Healthcare segment. The products of the company include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, Fazol, and others. Geographically, the company derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 290
Comparables
Valuation
|
Metric
|
APH
|
HIK
|
MCG
|
|---|---|---|---|
Price/Earnings (Normalized) | 8.89 | 10.41 | 12.10 |
Price/Book Value | 1.11 | 2.34 | 0.43 |
Price/Sales | 1.29 | 1.77 | 0.14 |
Price/Cash Flow | 6.69 | 9.65 | 2.01 |
Price/Earnings
APH
HIK
MCG
Financial Strength
|
Metric
|
APH
|
HIK
|
MCG
|
|---|---|---|---|
Quick Ratio | 1.97 | 0.87 | 0.60 |
Current Ratio | 2.93 | 1.66 | 0.66 |
Interest Coverage | −3.96 | 5.99 | 0.38 |
Quick Ratio
APH
HIK
MCG
Profitability
|
Metric
|
APH
|
HIK
|
MCG
|
|---|---|---|---|
Return on Assets (Normalized) | 5.83% | 10.41% | 1.11% |
Return on Equity (Normalized) | 11.32% | 22.07% | 4.16% |
Return on Invested Capital (Normalized) | 9.14% | 15.49% | 4.35% |
Return on Assets
APH
HIK
MCG
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Sgyjjhsnx | Xwhq | $86.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Xlmsmrkpw | Qlnpyhb | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Bwfstsz | Cvnf | $46.6 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Vvkkbqyv | Xmzd | $19.9 Bil | |||
| Viatris Inc
VTRS
| Gdqhmzv | Vxx | $13.6 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Qzfrgsc | Dsfr | $13.4 Bil | |||
| Catalent Inc
CTLT
| Zdqmbhdh | Wffxnr | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Ztrpmrxr | Qhgpng | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Vpgxxfcq | Shf | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Xlxbnpycz | Bthsc | $2.5 Bil |
United States